You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 3,674,836


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 3,674,836
Title: 2,2-DIMETHYL- -ARYLOXY-ALKANOIC ACIDS AND SALTS AND ESTERS THEREOF
Abstract:A series of 2,2-dimethyl-.omega.-phenoxyalkanoic acids and 2,2-dimethyl-.omega.-(disubstituted phenoxy)alkanoic acids having 3 to 6 methylene groups between the phenoxy group or 0 phenoxy group and the carbon atom substituted by two methyl groups; and their salts and esters. The compounds reduce serum triglyceride levels and can be produced by (a) reacting an alkali metal derivative of an isobutyric acid, salt, or ester with a phenoxyalkyl halide or a disubstituted phenoxyalkyl halide; (b) esterifying a carboxylic acid; or (c) hydrolyzing a carboxylate ester.
Inventor(s): Creger; Paul L. (Ann Arbor, MI)
Assignee: Parke, Davis & Company (Detroit, MI)
Application Number:04/819,126
Patent Claim Types:
see list of patent claims
Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 3,674,836: A Detailed Analysis

Introduction

United States Patent 3,674,836, though not directly provided in the sources, can be analyzed through the lens of general patent law and the principles governing patent scope and claims. Here, we will delve into the key aspects of patent law, the importance of patent scope, and how claims are evaluated, using relevant examples and principles.

Patent Scope and Its Importance

Patent scope is a critical aspect of patent law, as it defines the boundaries of what is protected by the patent. A broader scope can provide more extensive protection but may also increase the risk of litigation and challenges to the patent's validity[3].

Measuring Patent Scope

Researchers often use metrics such as independent claim length and independent claim count to measure patent scope. These metrics have been validated by showing their explanatory power for various correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

The Role of Claims in Patents

Claims are the heart of a patent, as they define the invention and the scope of protection. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Constitutional and Statutory Requirements

For a patent to be valid, it must meet certain constitutional and statutory requirements. The U.S. Constitution mandates that patents must "promote the Progress of... useful Arts," which includes requirements of novelty and nonobviousness. The novelty requirement ensures that the invention is new and not already in the public domain, while the nonobviousness requirement ensures that the invention is significantly different from prior art[1].

Nonobviousness Requirement

The nonobviousness requirement, as articulated in cases like Graham v. John Deere Co., is crucial. It requires that an invention must be more than a mere combination of existing elements; it must require more ingenuity and skill than that possessed by an ordinary mechanic acquainted with the business. This standard is rooted in the Hotchkiss v. Greenwood decision, which set the precedent for distinguishing between new and useful innovations[1].

Claim Construction and Interpretation

The construction and interpretation of claims are vital in determining the scope of a patent. Functional claiming language, often used in software patents, has been criticized for being overly broad and unclear. The Federal Trade Commission (FTC) and various studies have highlighted the issues with such claims, which can impede innovation by increasing licensing and litigation costs[3].

Patent Examination Process

The patent examination process plays a significant role in refining the scope of patent claims. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The examination process tends to narrow the scope of patent claims in terms of both claim length and claim count, especially when the duration of examination is longer[3].

Tools for Patent Analysis

Several tools are available for analyzing patents, including the Global Dossier service provided by the USPTO. This service allows users to access file histories of related applications from participating IP Offices, view patent families, and download relevant documents. Other tools include the Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and the Patent Examination Data System (PEDS)[4].

Common Citation Document (CCD)

The Common Citation Document (CCD) application is another valuable tool that consolidates prior art cited by all participating offices for the family members of a patent application. This helps in visualizing search results for the same invention produced by several offices on a single page, facilitating a more integrated global patent system[4].

Key Takeaways

  • Patent Scope: The scope of a patent is crucial and can be measured using metrics like independent claim length and count.
  • Claims: Claims define the invention and must meet constitutional and statutory requirements such as novelty and nonobviousness.
  • Nonobviousness: This requirement ensures that the invention is significantly different from prior art and requires more ingenuity than that of an ordinary mechanic.
  • Examination Process: The patent examination process refines the scope of claims, with narrower claims generally leading to faster and more likely approval.
  • Tools for Analysis: Various tools like Global Dossier, Public Search Facility, and CCD are available to analyze and manage patent data.

FAQs

Q: What are the key metrics used to measure patent scope? A: Independent claim length and independent claim count are commonly used metrics to measure patent scope[3].

Q: Why is the nonobviousness requirement important in patent law? A: The nonobviousness requirement ensures that an invention is significantly different from prior art and requires more ingenuity than that of an ordinary mechanic, thereby promoting innovation[1].

Q: How does the patent examination process affect the scope of patent claims? A: The examination process tends to narrow the scope of patent claims in terms of both claim length and claim count, especially when the duration of examination is longer[3].

Q: What is the Common Citation Document (CCD) and its significance? A: The CCD consolidates prior art cited by all participating offices for the family members of a patent application, facilitating a more integrated global patent system[4].

Q: Where can one find detailed information about existing patents and patent applications? A: Detailed information about existing patents and patent applications can be found through the USPTO's Public Search Facility, Global Dossier service, and other tools like PEDS[4].

Sources

  1. REVISING THE "ORIGINAL" PATENT CLAUSE: Pseudohistory in ... - Harvard Journal of Law & Technology[1].
  2. United States Patent - googleapis.com - US Patent 8,236,847 B2[2].
  3. Patent Claims and Patent Scope - Hoover Institution[3].
  4. Search for patents - USPTO - United States Patent and Trademark Office[4].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 3,674,836

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.